return to results page

VAERS ID: 2275416

AGE: 50| SEX: F|State: CA

Description

congestion; sneezing; Original symptoms (fever, chills, cough) started 28Apr Positive Covid test; Original symptoms (fever, chills, cough) started 28Apr Positive Covid test; Original symptoms (fever, chills, cough) started 28Apr Positive Covid test; Original symptoms (fever, chills, cough) started 28Apr Positive Covid test; Original symptoms (fever, chills, cough) started 28Apr Positive Covid test; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 50-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), in Apr2021 as dose 1, single (Batch/Lot number: unknown), in left arm and in May2021 as dose 2, single (Batch/Lot number: unknown) at the age of 50 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), in Dec2021 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Pfizer, vaccine dose number=2; pfizer vaccine dose number=1; Moderna dose number=unknown" (unspecified if ongoing), notes: Pfizer, vaccine dose number=2; pfizer vaccine dose number=1; Moderna dose number=unknown. The patient took concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 28Apr2022, outcome "unknown", PYREXIA (non-serious), CHILLS (non-serious), COUGH (non-serious) all with onset 28Apr2022, outcome "recovered" (05May2022) and all described as "Original symptoms (fever, chills, cough) started 28Apr Positive Covid test"; COVID-19 (medically significant) with onset 29Apr2022, outcome "unknown", described as "Original symptoms (fever, chills, cough) started 28Apr Positive Covid test"; NASAL CONGESTION (non-serious) with onset 07May2022, outcome "recovering", described as "congestion"; SNEEZING (non-serious) with onset 07May2022, outcome "recovering". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (29Apr2022) Positive; (06May2022) Negative; (07May2022) Negative; (08May2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Therapeutic measures were not taken as a result of nasal congestion, sneezing, pyrexia, chills, cough. Clinical course included After completing the 5-day course of Paxlovid and testing negative 2 days in a row, symptoms returned and patient tested positive again. No allergies reported. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.

Symptoms

COVID-19, Pyrexia, Chills, SARS-CoV-2 test, Cough, Sneezing, Drug ineffective, Nasal congestion

Vaccines

VAX DATE: 30 April 2021 | ONSET DATE: 27 April 2022 | DAYS TO ONSET: 362
Vaccine TypeManufacturerVaccine NameDoseRouteSiteLot
  • COVID19
  • PFIZERBIONTECH
  • COVID19 (COVID19 (PFIZER-BIONTECH))
  • 2
  • LA

RECVDATE:12 May 2022
CAGE_YR:
CAGE_MO:
RPT_DATE:
DIED:
DATEDIED:
L_THREAT:
ER_VISIT:
HOSPITAL:
HOSPDAYS:
X_STAY:
DISABLE:
RECOVD:N
LAB_DATA:Test Date: 20220429; Test Name: Covid test; Test Result: Positive ; Test Date: 20220506; Test Name: Covid test; Test Result: Negative ; Test Date: 20220507; Test Name: Covid test; Test Result: Negative ; Test Date: 20220508; Test Name: Covid test; Test Result: Positive
V_ADMINBY:UNK
OTHER_MEDS:
CUR_ILL:
HISTORY:Medical History/Concurrent Conditions: Interchange of vaccine products (Pfizer, vaccine dose number=2; pfizer vaccine dose number=1; Moderna dose number=unknown)
PRIOR_VAX:
SPLTTYPE:USPFIZER INC202200690185
FORM_VERS:2
TODAYS_DATE:11 May 2022
BIRTH_DEFECT:
OFC_VISIT:
ER_ED_VISIT:
ALLERGIES:
V_FUNDBY:
return to results page

Questions? Comments? Bugs?
[email protected]
Due to the high volume of inquiries, please be patient with response times.

AND PLEASE read the FAQ first.

OpenVAERS is a private organization that posts publicly available CDC/FDA data of injuries reported post-vaccination. Reports are not proof of causality.